NCT01638104 - ANX-042 Healthy Volunteer Dose Escalation Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

ANX-042

Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

DRUG

Placebo

Administered once by 12 hour continuous intravenous infusion with D5W (USP)

Trial Locations (1)

68502

Celerion, Lincoln